Product Name | MF | CAS | Details |
---|
Bafrekalant | C29H31ClN6O2 | 2256770-44-0 | Details |
Ontazolast | C21H25N3O | 147432-77-7 | Details |
Regorafenib mesylate | C22H19ClF4N4O6S | 835621-08-4 | Details |
PTP1B-IN-15 | C19H17Br2NO5S | 765317-71-3 | Details |
Tampramine | C23H24N4 | 83166-17-0 | Details |
DG013A | C27H37N4O4P | 2007955-07-7 | Details |
TXA6101 | C18H10BrF5N2O3 | 1459695-66-9 | Details |
GNF2133 hydrochloride | 2561414-57-9 | Details |
Ciproquazone | C19H18N2O2 | 33453-23-5 | Details |
Tau-aggregation and neuroinflammation-IN-1 | C25H20N2O7 | 2175953-98-5 | Details |
HAMI 3379 | C34H45NO8 | 1245653-57-9 | Details |
Paltimatrectinib | C20H15F5N6 | 2353522-15-1 | Details |
Oxepinac | C16H12O4 | 55689-65-1 | Details |
OTS964 | C23H24N2O2S | 1338542-14-5 | Details |
MK-6186 | C21H12Cl2N6O | 1034474-19-5 | Details |
PND-1186 hydrochloride | C25H27ClF3N5O3 | 1356154-94-3 | Details |
Darglitazone Sodium | C23H20N2O4S.Na | 149904-87-0 | Details |
ST247 | C19H26N2O5S2 | 1356497-91-0 | Details |
Ro 363 hydrochloride | C19H26ClNO6 | 250580-70-2 | Details |
Safironil | C15H23N3O4 | 134377-69-8 | Details |
HIV-1 inhibitor-31 | C21H13Cl2N3O2 | 920036-04-0 | Details |
Efpeglenatide | 1296200-77-5 | Details |
Ifetroban sodium | C25H33N2NaO5 | 156715-37-6 | Details |
(Rac)-Norcisapride | C14H20ClN3O3 | 84946-16-7 | Details |
NDB | C26H28Cl2N2O2 | 1660153-08-1 | Details |
ALDH2 modulator 1 | C18H18ClFN2O3 | 1629615-99-1 | Details |
Org 43553 | C24H30N6O3S2 | 501444-88-8 | Details |
UNC4203 | C30H44N6O | 1818234-19-3 | Details |
Duocarmycin analog-2 | C29H23ClN4O3 | 1164275-01-7 | Details |
Aspochalasin M | C24H35NO4 | 1173040-34-0 | Details |
DS-6930 | C23H21N3O4 | 1242328-82-0 | Details |
CDK5-IN-2 | C29H28FN5O | 2639542-22-4 | Details |
Rociclovir PM | C9H13N5O3 | 89419-23-8 | Details |
NF-κB/MAPK-IN-1 | C27H27NO7 | 2413940-56-2 | Details |
CCT369260 | C24H31ClF2N6O2 | 2647503-57-7 | Details |
CJ-2360 | C27H30FN5O2 | 2226742-61-4 | Details |
(15aS)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine | C41H36O2P2 | 486429-95-2 | Details |
BRL-15572 hydrochloride | C25H28Cl2N2O | 1173022-77-9 | Details |
Mytoxin B | C29H36O9 | 105049-15-8 | Details |
MCT1-IN-3 | C22H19N3O4 | 2878360-80-4 | Details |
CB1/2 agonist 3 | C25H41NO2 | 2772655-86-2 | Details |
UCM-1306 | C14H14FNO2S | 2258608-78-3 | Details |
HTT-D3 | C23H25FN6 | 2254502-89-9 | Details |
Losulazine | C27H22F4N4O3S | 72141-57-2 | Details |
PI3K/mTOR Inhibitor-4 | C27H22FN3O6S | 2361215-32-7 | Details |
Nrf2 activator-4 | C23H24ClF3N2O3 | 2383016-68-8 | Details |
Glucametacine | C25H27ClN2O8 | 52443-21-7 | Details |
Pipoxizine | C24H31NO3 | 55837-21-3 | Details |
S 17092 | C22H28N2O2S | 176797-26-5 | Details |
Laniquidar | C37H36N4O3 | 197509-46-9 | Details |
ABC44 | C31H40N6O5 | 1831135-46-6 | Details |
(16aR)-1,16-Bis(diphenylphosphino)-6,7,8,9,10,11-hexahydrodibenzo[b,d][1,6]dioxacyclododecine | C42H38O2P2 | 301847-92-7 | Details |
Penamecillin | C19H22N2O6S | 983-85-7 | Details |
Xanthine amine congener hydrochloride | C21H29ClN6O4 | 1783977-95-6 | Details |
Sovesudil | C23H22FN3O3 | 1333400-14-8 | Details |
Sipagladenant | C20H19N3O4S | 858979-50-7 | Details |
Epitinib | C24H26N6O2 | 1203902-67-3 | Details |
BMT-090605 hydrochloride | C21H25ClN4O2 | 2231664-45-0 | Details |
GS-6620 PM | C13H15N5O4 | 1191237-49-6 | Details |
Elbanizine | C26H31N5O2 | 110629-41-9 | Details |
Nezulcitinib | C30H37N7O2 | 2412496-23-0 | Details |
IXA6 | C22H20ClN3O3S | 1021106-40-0 | Details |
BACE-IN-1 | C22H16ClN5O2 | 1254166-60-3 | Details |
Camonagrel | 105920-77-2 | Details |
CSF1R-IN-3 | C30H38N8O4 | 2760584-90-3 | Details |
Ezurpimtrostat hydrochloride | C25H32Cl2N4 | 1914148-73-4 | Details |
ZINC09659342 | C23H15F3N2O4 | 1668604-47-4 | Details |
Claficapavir | C17H12ClNO4S2 | 2055732-24-4 | Details |
ONO-9780307 | C30H35NO7 | 856691-44-6 | Details |
Tripelennamine citrate | C22H29N3O7 | 6138-56-3 | Details |
Clevudine triphosphate | O10P3-5 | 174625-00-4 | Details |
DDO-02005 | C21H26ClN3O2 | 1186049-44-4 | Details |
Inaperisone | C16H23NO | 99323-21-4 | Details |
MK-8153 | C24H28N2O6 | 1548286-45-8 | Details |
RIPK3-IN-1 | C29H25FN4O4 | 2361139-70-8 | Details |
BS-181 dihydrochloride | C22H33ClN6 | 1883548-83-1 | Details |
Methyl 3-(3-bromophenyl)-1,2-oxazole-5-carboxylate | C11H8BrNO3 | 377059-68-2 | Details |
ITK inhibitor 6 | C28H24F2N4O2 | 2404604-06-2 | Details |
CB1R antagonist 1 | C18H23F3N2O3S | 334668-69-8 | Details |
A2A receptor antagonist 3 | C26H26N6O2 | 2738606-83-0 | Details |
SARS-CoV-2 nsp13-IN-1 | C27H20N4O2 | 1005304-44-8 | Details |
BMS-566419 | C28H30FN5O2 | 566161-24-8 | Details |
Pafenolol | C18H31N3O3 | 75949-61-0 | Details |
BI-10 | C23H17BrN2O | 2759037-58-4 | Details |
Tubulin inhibitor 23 | C26H23NO6S | 170488-57-0 | Details |
ML138 | C19H14Cl2N4OS | 1355243-24-1 | Details |
18-Deoxyherboxidiene | C25H42O5 | 1200128-66-0 | Details |
(15aR)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine | C41H36O2P2 | 301847-91-6 | Details |
4,4'-(Triaz-1-ene-1,3-diyl)dibenzimidamide hydrochloride | C14H16ClN7 | 2331268-15-4 | Details |
GSK2647544 | C24H18ClF3N4O3 | 1380426-95-8 | Details |
Edecesertib | C22H22FN7O2 | 2408839-73-4 | Details |
BSJ-01-175 | C30H33ClN6O2 | 2227392-55-2 | Details |
CQ211 | C26H22F3N7O2 | 2648986-65-4 | Details |
Glyoxalase I inhibitor 2 | C24H23N3O4S | 2314467-61-1 | Details |
SMO-IN-3 | C27H25F4N3O2 | 2376914-71-3 | Details |
10-Formyl-5,8-dideazafolic acid | C22H21N5O7 | 61038-31-1 | Details |
Vamotinib | C29H27F3N6O | 1416241-23-0 | Details |
EHT 5372 | C17H11Cl2N5OS | 1425945-63-6 | Details |
Quinine hydrobromide | C20H25BrN2O2 | 549-49-5 | Details |
BTA-188 | C21H28N4O2 | 314062-80-1 | Details |
Product Total: Product Page: | ||||
59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 |